Radiopharmaceuticals: all 1,299 studies that test it
Page 12 of 13. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.
- PET Study of Breast Cancer Patients Using [68Ga]ABY-025CompletedNCT01858116Phase 1/2
- MIBG for Refractory Neuroblastoma and PheochromocytomaCompletedNCT01850888Not applicable
- 177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETsCompletedNCT01842165Phase 3
- Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel CleansingCompletedNCT01840553Phase 3
- 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer PatientsCompletedNCT01832116Phase 1
- Clinical Value of 89Zr-trastuzumab PETCompletedNCT01832051Phase 2
- CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD SubjectsCompletedNCT01826773Phase 2
- 18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing SarcomaCompletedNCT01825902Early Phase 1
- Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin LymphomaStatus unknownNCT01811368Phase 2
- Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone MetastasisCompletedNCT01810770Phase 3
- 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of GliomaStatus unknownNCT01801371Early Phase 1
- Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab TherapyCompletedNCT01789827Early Phase 1
- Open-Label Study of I-131-CLR1404 in Subjects With Recurrent GliomaWithdrawnNCT01778088Phase 2
- REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CTWithdrawnNCT01762592Phase 3
- Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 ParkinsonismCompletedNCT01759888Phase 2
- An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)WithdrawnNCT01747512Phase 2
- 99mTc-3PRGD2 SPECT/CT in Lung Cancer PatientsStatus unknownNCT01737112Early Phase 1
- Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical ADCompletedNCT01723553Phase 1
- 18F-FLT PET for Suspicious Findings on Mammography and Breast UltrasoundStatus unknownNCT01713049Not applicable
- Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy ControlsCompletedNCT01710371Phase 1
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary TumorsCompletedNCT01689727Phase 2
- Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial CarcinomaCompletedNCT01689714Phase 2
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell CarcinomaCompletedNCT01689662Phase 2
- Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer PatientsCompletedNCT01689636Phase 1
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial CancerCompletedNCT01686256Phase 1
- Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid TumorCompletedNCT01684098Phase 2
- Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPIWithdrawnNCT01681524Phase 3
- 131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell LymphomaStatus unknownNCT01678417Phase 2
- 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell LymphomaStatus unknownNCT01678404Phase 2
- A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)Status unknownNCT01676558Phase 2
- 18F-FDG PET/CT for IgG4-Related DiseaseStatus unknownNCT01665196Early Phase 1
- Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the BreastCompletedNCT01659645Early Phase 1
- 68Ga-BNOTA-PRGD2 PET/CT in Evaluation of StrokeStatus unknownNCT01656785Early Phase 1
- 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404CompletedNCT01654874Phase 1
- PiB PET Scanning in Speech and Language Based DementiasCompletedNCT01623284Phase 1
- Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesCompletedNCT01618370Phase 3
- A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate CancerCompletedNCT01615406Phase 1
- Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young AdultsCompletedNCT01609335Phase 1
- Effects of Brain Beta-Amyloid on Postoperative CognitionActive, not recruitingNCT01606488Phase 4
- 124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot StudyTerminatedNCT01583842Early Phase 1
- Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell CarcinomaActive, not recruitingNCT01582204Not applicable
- Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node DissectionCompletedNCT01572701Phase 1
- Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese PatientsCompletedNCT01565746Phase 1
- Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate CancerCompletedNCT01543659Phase 1/2
- 68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial InfarctionStatus unknownNCT01542073Early Phase 1
- C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate AdenocarcinomaCompletedNCT01530269Phase 2
- 68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer PatientsStatus unknownNCT01527058Early Phase 1
- 68Ga-DOTATATE PET/CT in Oncogenic OsteomalaciaStatus unknownNCT01524016Early Phase 1
- Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) ImagingTerminatedNCT01522378Phase 1
- A Trial of 18F-AV-133 Positron Emission Tomography (PET)TerminatedNCT01515384Phase 1
- A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.WithdrawnNCT01510561Phase 1
- A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)CompletedNCT01503944Phase 1/2
- Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has ReturnedCompletedNCT01495663Phase 1
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian CancerTerminatedNCT01494012Phase 1
- Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid TumorsTerminatedNCT01479023Phase 1
- Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin LymphomaCompletedNCT01476839Phase 1
- An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor TypesCompletedNCT01472003Phase 1
- Imaging Malignant Glioma With 68Ga-DOTATOC PET/CTCompletedNCT01460706Phase 2/3
- A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine TumorsCompletedNCT01456078Phase 2
- Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular LymphomaCompletedNCT01446562Phase 2
- To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid CancerCompletedNCT01437254Phase 1
- Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary OriginTerminatedNCT01434459Phase 1
- Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate CancerCompletedNCT01417182Phase 1
- Measurement of Gastric Emptying During and After COLOKIT® IntakeCompletedNCT01398098Phase 2
- 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine TumorsStatus unknownNCT01373736Phase 3
- Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck CancerCompletedNCT01359267Early Phase 1
- Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+Status unknownNCT01354457Phase 1/2
- PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate CarcinomaCompletedNCT01304485Phase 2
- 18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET ImagingCompletedNCT01283347Phase 2
- Clinical Study of Microdosing Carboplatin in Lung or Bladder CancerTerminatedNCT01261299Early Phase 1
- Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and WaterTerminatedNCT01246869Phase 1
- 177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine NeoplasmsCompletedNCT01237457Phase 2
- Efficacy, Safety and Tolerability of Split-dose of PEG Compared With NaP Solution for Colonoscopy Preparation: A Randomized, Controlled TrialCompletedNCT01229800Phase 3
- Clinical Evaluation of the New Hypoxia Imaging Agent HX4CompletedNCT01213030Phase 1/2
- Colon Cancer Prevention Using SeleniumStatus unknownNCT01211561Early Phase 1
- Exploration of Tumor Accumulation of BAY94-9392 in Patients With CancerCompletedNCT01186601Phase 1
- Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant GliomaCompletedNCT01165632Early Phase 1
- Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and ControlsCompletedNCT01160263Phase 3
- 90Y-ibritumomab Tiuxetan Consolidation After 6th R-CHOP Chemotherapy in Patients With Bulky Diffuse Large B Cell LymphomaCompletedNCT01157988Phase 2
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease ProgressionCompletedNCT01141023Phase 2
- Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate CancerWithdrawnNCT01132599Phase 2
- Influence of Selenium on Prostate Cancer Related BiomarkersCompletedNCT01112449Not applicable
- Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or InflammationCompletedNCT01103310Phase 1
- BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant DiseaseCompletedNCT01070485Phase 2
- A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or LymphomaTerminatedNCT01065805Phase 1/2
- A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal CancerCompletedNCT01051479Phase 1
- A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male VolunteersCompletedNCT01034748Phase 1
- Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxCompletedNCT01020097Not applicable
- Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy VolunteersCompletedNCT01009359Phase 1
- Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow InvolvementCompletedNCT00992758Phase 1
- A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate CancerCompletedNCT00992745Phase 1
- Effects of Delta-9-THC and Iomazenil in Healthy HumansCompletedNCT00982982Early Phase 1
- Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and PatientsCompletedNCT00961831Phase 1
- A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the KneeStatus unknownNCT00954629Phase 3
- Exploratory and Safety Study of [F-18]W372CompletedNCT00954369Early Phase 1
- Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent TumorsTerminatedNCT00944372Phase 4
- Dopaminergic Loss and Pain in Parkinson's DiseaseCompletedNCT00940914Phase 2
- Study of [3H] BMS747158 in Healthy Male SubjectsCompletedNCT00930631Phase 1
- Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid TumorsCompletedNCT00925275Phase 1
- Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell LymphomaTerminatedNCT00906841Phase 2